Vimarsana
Biggest News Aggregation in the World

Page 6 - Peter Altman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Altman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Altman Today - Breaking & Trending Today

BioCardia, Inc. (NASDAQ:BCDA) Q2 2023 Earnings Call Transcript - Vimarsana News

BioCardia, Inc. (NASDAQ:BCDA) Q2 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2023 Second Quarter Conference Call. At this time, all participants are in a listen-only mode.

BioCardia Completes Submission of CardiAMP Cell Therapy System in Heart Failure to Japan's Pharmaceutical Medical Device Agency - Vimarsana News

BioCardia Completes Submission of CardiAMP Cell Therapy System in Heart Failure to Japan's Pharmaceutical Medical Device Agency

SUNNYVALE, Calif. , July 05, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment…

BioCardia seeks Japanese approval of heart failure cell therapy - Vimarsana News

BioCardia seeks Japanese approval of heart failure cell therapy

BioCardia (Nasdaq:BCDA) announced that it completed the submission of its CardiAMP cell therapy system to Japan's regulatory authorities.

BioCardia : Termination of Material Agreement - Vimarsana News

BioCardia : Termination of Material Agreement

Bcda20230629_8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ...

The Huntington's Michael Maso exits the stage - Vimarsana News

The Huntington's Michael Maso exits the stage

A leader at the Huntington since its founding four decades ago, Maso, 71, ranks as one of the most consequential figures in Boston theater history.